Physician profile
Dixie Fox
NPI 1669792099
$1,540.52
in general payments reported to CMS, 2019-2025
19 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $156 · 2021: $263 · 2022: $76.23 · 2023: $126 · 2024: $59.69 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $718.51 | 2019-2025 | Augment Injectable, Viaflow, Citrefix |
| Organogenesis INC. | $248.01 | 2019-2023 | Puraply |
| Wright Medical Technology, INC. | $114.74 | 2019 | |
| Smith+Nephew, INC. | $50.80 | 2019-2021 | |
| Bioventus LLC | $43.99 | 2019-2020 | |
| Misonix INC | $41.29 | 2019-2020 | |
| Elite Orthopedics, LLC | $40.41 | 2023-2025 | |
| Treace Medical Concepts, INC. | $37.71 | 2022-2025 | |
| Integra Lifesciences Corporation | $37.62 | 2019 | |
| Celularity INC. | $33.00 | 2019 | |
| Abbvie INC. | $30.17 | 2025 | |
| Checkpoint Surgical, INC | $23.06 | 2023 | Checkpoint Stimulators |
| Ani Pharmaceuticals, INC. | $21.63 | 2025 | Purified Cortrophin Gel |
| Averitas Pharma INC. | $19.96 | 2025 | Qutenza |
| Kerecis Limited | $19.48 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $17.69 | 2021 | |
| Aroa Biosurgery Incorporated | $17.12 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.73 | 2022 | |
| Orthofix Medical, INC. | $9.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dixie Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.